{
  "url": "https://www.law.cornell.edu/regulations/new-york/12-NYCRR-441.8",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 441.8 - Medical Treatment Guidelines and Formulary",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 441.8 - Medical Treatment Guidelines and Formulary\n\nState Regulations\n\nIn the event that a conflict exists between the Board's\nmedical treatment guidelines and the New York Formulary, the provisions of the\nmedical treatment guidelines shall prevail, unless the drug was prescribed in\naccordance with Phase A or Phase B of the Formulary. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 12\nยง\n441.8\n\nAdopted\n\nNew\n\nYork State Register June 5, 2019/Volume XLI, Issue 22, eff. 6/5/2019\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 10402
}